| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10930613 | Cytotherapy | 2014 | 14 Pages |
Abstract
We demonstrated that iHPL is safer than HPL and represents a good, Good Manufacturing Practice-compliant alternative to FBS for MSC clinical production that is even more advantageous in terms of cellular growth and stemness.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Sara Castiglia, Katia Mareschi, Luciana Labanca, Graziella Lucania, Marco Leone, Fiorella Sanavio, Laura Castello, Deborah Rustichelli, Elena Signorino, Monica Gunetti, Massimiliano Bergallo, Anna Maria Bordiga, Ivana Ferrero, Franca Fagioli,